Evidence map›Paper›PMID 30976490›Full record

ReviewActa pharmaceutica Sinica. B2019

Small molecules for fat combustion: targeting obesity.

Jingxin Liu, Yitao Wang, Ligen Lin

Abstract readReview
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Vanadium(IV)-chlorodipicolinate alleviates hepatic steatosis via the AMPK/PGC-1α/CPT1a axis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cold exposure-inducedActa pharmaceutica Sinica. B · 2026
    Article
  10. Article
  11. Review
  12. Theranostics · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Dietary Supplements for Weight Loss and Drug Interactions.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jingxin LiuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa 999078, Macau, China.
Yitao WangState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa 999078, Macau, China.
Ligen LinState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa 999078, Macau, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is increasing in an alarming rate worldwide, which causes higher risks of some diseases, such as type 2 diabetes, cardiovascular diseases, and cancer. Current therapeutic approaches, either pancreatic lipase inhibitors or appetite suppressors, are generally of limited effectiveness. Brown adipose tissue (BAT) and beige cells dissipate fatty acids as heat to maintain body temperature, termed non-shivering thermogenesis; the activity and mass of BAT and beige cells are negatively correlated with overweight and obesity. The existence of BAT and beige cells in human adults provides an effective weight reduction therapy, a process likely to be amenable to pharmacological intervention. Herein, we combed through the physiology of thermogenesis and the role of BAT and beige cells in combating with obesity. We summarized the thermogenic regulators identified in the past decades, targeting G protein-coupled receptors, transient receptor potential channels, nuclear receptors and miscellaneous pathways. Advances in clinical trials were also presented. The main purpose of this review is to provide a comprehensive and up-to-date knowledge from the biological importance of thermogenesis in energy homeostasis to the representative thermogenic regulators for treating obesity. Thermogenic regulators might have a large potential for further investigations to be developed as lead compounds in fighting obesity.

Indexed as

AKT, protein kinase BALDH9, aldehyde dehydrogenase 9AMPK, AMP-activated protein kinaseATP, adenosine triphosphateBA, bile acidsBAT, brown adipose tissueBeige cellsBMP8b, bone morphogenetic protein 8bBrown adipose tissuecAMP, cyclic adenosine monophosphateC/EBPα, CCAAT/enhancer binding protein αcGMP, cyclic guanosine monophosphateCidea, cell death-inducing DNA fragmentation factor α-like effector ACLA, cis-12 conjugated linoleic acidCRABP-II, cellular RA binding protein type IICRE, cAMP response elementDio2, iodothyronine deiodinase type 2ERE, estrogen response elementERs, estrogen receptorsFAS, fatty acid synthaseFGF21, fibroblast growth factor 21GPCRs, G protein-coupled receptorsHFD, high fat dietLXR, liver X receptorsMAPK, mitogen-activated protein kinaseObesityOXPHOS, oxidative phosphorylationPDEs, phosphodiesterasesPET-CT, positron emission tomography combined with computed tomographyPGC-1α, peroxisome proliferator-activated receptor γ coactivator 1-αPKA, protein kinase APPARs, peroxisome proliferator-activated receptorsPPREs, peroxisome proliferator response elementsPRDM16, PR domain containing 16PTP1B, protein-tyrosine phosphatase 1BPXR, pregnane X receptorRARE, RA response elementRA, retinoic acidRAR, RA receptorRMR, resting metabolic rateRXR, retinoid X receptorSIRT1, silent mating type information regulation 2 homolog 1SNS, sympathetic nervous systemTFAM, mitochondrial transcription factor AThermogenesisTMEM26, transmembrane protein 26TRPs, transient receptor potential cation channelsUCP1, uncoupling protein 1Uncoupling protein 1VDRE, VDR response elementsVDR, vitamin D receptorWAT, white adipose tissueβ3-AR, β3-adrenergic receptor

Identifiers

PMID30976490
PMCPMC6438825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.